NTRK inhibitors are a class of targeted therapy drugs designed to block the activity of neurotrophic tyrosine receptor kinases (NTRK). These kinases are involved in the growth and survival of cells. Abnormalities in the NTRK genes, such as fusions, can lead to uncontrolled cell growth and cancer.
